These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29184533)

  • 21. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.
    DiMarzio M; Pilitsis JG; Gee L; Peng S; Prusik J; Durphy J; Ramirez-Zamora A; Hanspal E; Molho E; McCallum SE
    Neuromodulation; 2018 Aug; 21(6):617-622. PubMed ID: 29608802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
    Ehm G; Kim HJ; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Lim YH; Jeon B; Paek SH
    J Neurosurg; 2019 Nov; 131(5):1508-1513. PubMed ID: 30497175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
    Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.
    Hanna JA; Scullen T; Kahn L; Mathkour M; Gouveia EE; Garces J; Evans LM; Lea G; Houghton DJ; Biro E; Bui CJ; Sulaiman OA; Smith RD
    J Neurosurg; 2019 Sep; 131(3):807-812. PubMed ID: 30265192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease motor subtypes and bilateral GPi deep brain stimulation: One-year outcomes.
    Tsuboi T; Lemos Melo Lobo Jofili Lopes J; Patel B; Legacy J; Moore K; Eisinger RS; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    Parkinsonism Relat Disord; 2020 Jun; 75():7-13. PubMed ID: 32428801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.
    Aviles-Olmos I; Kefalopoulou Z; Tripoliti E; Candelario J; Akram H; Martinez-Torres I; Jahanshahi M; Foltynie T; Hariz M; Zrinzo L; Limousin P
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1419-25. PubMed ID: 24790212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Waldthaler J; Bopp M; Kühn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
    Brain Stimul; 2021; 14(5):1109-1117. PubMed ID: 34352356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's Disease Motor Subtypes Show Different Responses to Long-Term Subthalamic Nucleus Stimulation.
    Xu C; Zhuang P; Hallett M; Zhang Y; Li J; Li Y
    Front Hum Neurosci; 2018; 12():365. PubMed ID: 30337863
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease.
    Blasberg F; Wojtecki L; Elben S; Slotty PJ; Vesper J; Schnitzler A; Groiss SJ
    Neuromodulation; 2018 Aug; 21(6):541-547. PubMed ID: 29532560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A low-cost vision system based on the analysis of motor features for recognition and severity rating of Parkinson's Disease.
    Buongiorno D; Bortone I; Cascarano GD; Trotta GF; Brunetti A; Bevilacqua V
    BMC Med Inform Decis Mak; 2019 Dec; 19(Suppl 9):243. PubMed ID: 31830986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
    Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
    Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and long-term cognitive effects of deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease.
    Philipson J; Blomstedt P; Fredricks A; Hariz M; Stenmark Persson R; Jahanshahi M
    J Neurosurg; 2021 Feb; 134(2):357-365. PubMed ID: 32032954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.
    Sasaki F; Oyama G; Sekimoto S; Nuermaimaiti M; Iwamuro H; Shimo Y; Umemura A; Hattori N
    Parkinsonism Relat Disord; 2021 Mar; 84():47-51. PubMed ID: 33556765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.
    Kahn L; Mathkour M; Lee SX; Gouveia EE; Hanna JA; Garces J; Scullen T; McCormack E; Riffle J; Glynn R; Houghton D; Lea G; Biro EE; Bui CJ; Sulaiman OA; Smith RD
    Clin Neurol Neurosurg; 2019 Apr; 179():67-73. PubMed ID: 30851616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.
    Georgiev D; Dirnberger G; Wilkinson L; Limousin P; Jahanshahi M
    Exp Brain Res; 2016 Apr; 234(4):1133-43. PubMed ID: 26758720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.